82720-42-1Relevant academic research and scientific papers
Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo
Deng, Xuemei,Feng, Hanzhong,Feng, Yiyue,He, Yongxing,Jiang, Weifan,Li, Junfang,Li, Zhao,Liu, Dan,Lu, Yingmei,Shi, Tao,Wang, Zhen,Zhang, Honghua,Zhang, Jian
, (2021/10/12)
Although gastric cancer has become a major public health problem, oral agents applied in clinics for gastric cancer therapy are scarce. Therefore, to explore new oral chemical entities with high efficiency and low toxicity, 41 o-aminobenzamide derivatives based on the scaffolds of MS-275 and SAHA were designed, synthesized, and evaluated for their anti-gastric cancer abilities in vitro and in vivo. Structure-activity relationships were discussed, leading to the identification of compounds F8 (IC50 = 0.28 μM against HGC-27 cell) and T9 (IC50 = 1.84 μM against HGC-27 cell) with improved cytotoxicity, anti-gastric cancer proliferation potency, induction of cell apoptosis and cell cycle arrest ability, inhibition of cell migration and invasion. What is worth mentioning is that compound F8 was more efficient and less toxic than the positive drug capecitabine in vivo on the HGC-27-xenograft model. Meanwhile, compound F8 exhibited suitable pharmacokinetic properties and less acute toxicity (LD50 > 1000 mg/kg). Besides, western blotting analysis, IHC analysis, differentially expressed proteins analysis and ABPP experiment indicated that compound F8 could modulate molecular pathways involved in apoptosis and cell cycle progression. Consequently, compound F8 is a strong candidate for the development of human gastric cancer therapy.
Dichotomy of reductive addition of amines to cyclopropyl ketones vs pyrrolidine synthesis
Afanasyev, Oleg I.,Tsygankov, Alexey A.,Usanov, Dmitry L.,Chusov, Denis
supporting information, p. 5968 - 5970 (2016/11/29)
An interesting catalytic dichotomy was discovered: switching between simple ligand-free catalysts leads to fundamentally different outcomes of reductive reaction between amines and α-carbonylcyclopropanes. Whereas a rhodium catalyst leads to the tradition
Boron trifluoride-methanol complex. Mild and powerful reagent for deprotection of acetylated amines. Scope and selectivity
Miltsov, Sergey,Karavan, Vladimir,Misharev, Alexandr,Alonso-Chamarro, Julian,Puyol, Mar
supporting information, p. 641 - 644 (2016/01/26)
A boron trifluoride-methanol complex demonstrated remarkable deprotection selectivity against commonly used amino-protecting groups in the deacetylation of acetanilides and high sensitivity to the steric hindrance of substrates. The scope and limitations of the reaction were explored.
COMPOUNDS USEFUL AS CSF1 MODULATORS
-
Paragraph 00188; 00189, (2016/04/26)
This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.
Chemoselective N-deacetylation under mild conditions
Sultane, Prakash R.,Mete, Trimbak B.,Bhat, Ramakrishna G.
supporting information, p. 261 - 264 (2014/01/06)
A mild and efficient chemoselective N-deacetylation using the Schwartz reagent at room temperature in rapid time is described. The mild and neutral conditions enable orthogonal N-deacetylation in the presence of some of the common protecting groups (viz. Boc, Fmoc, Cbz, Ts). The deprotection conditions did not induce any epimerization at the chiral amino centre.
A magnetically separable gold catalyst for chemoselective reduction of nitro compounds
Park, Sungho,Lee, In Su,Park, Jaiwook
supporting information, p. 395 - 399 (2013/02/23)
Magnetically separable gold-nanoparticle catalyst was prepared, and it showed excellent activity for chemoselective reduction of nitroarenes with hydrosilanes. The Royal Society of Chemistry 2013.
PROTEIN KINASE INHIBITORS
-
Page/Page column 39-40, (2012/10/18)
The present invention relates to novel kinase inhibitors. Compounds of this class have been found to be effective inhibitors of protein kinases; including members of PDGFR and VEGFR families.
Simple one-pot synthesis of Rh-Fe3O4 heterodimer nanocrystals and their applications to a magnetically recyclable catalyst for efficient and selective reduction of nitroarenes and alkenes
Jang, Youngjin,Kim, Seyoung,Jun, Samuel Woojoo,Kim, Byung Hyo,Hwang, Sunhwan,Song, In Kyu,Kim, B. Moon,Hyeon, Taeghwan
supporting information; experimental part, p. 3601 - 3603 (2011/04/26)
A simple synthesis of Rh-Fe3O4 heterodimer nanocrystals was achieved by controlled one-pot thermolysis. The nanocrystals exhibited excellent activities for the selective reduction of nitroarenes and alkenes. Furthermore the nanocrystal catalyst could be easily separated by a magnet, and recycled eight times without losing the catalytic activity.
Fe3O4 nanoparticles: A conveniently reusable catalyst for the reduction of nitroarenes using hydrazine hydrate
Kim, Seyoung,Kim, Eunsuk,Kim, B. Moon
experimental part, p. 1921 - 1925 (2011/10/17)
A magnetic personality: Commercially available Fe3O4 nanoparticles were utilized for efficient nitroarene reductions, and could be recycled up to 10 times using magnetic separation, whilst retaining activity (99 % aniline yield in each case without any side-products). Excellent chemoselectivity for reduction of the nitro versus other functional groups, such as halogen, ester, O-benzyl, and N-Cbz groups, was observed.
